Abzena, the leading end-to-end integrated contract and development manufacturing organization for complex biologics and bioconjugates, and Argonaut Manufacturing Services, Inc., a cGMP CDMO serving...
Beyond Air, Inc., a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to...
Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with cancer and inflammatory diseases, today announced...
PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, announced the introduction of GlueSEEKER™. The new phenotypic screening platform...
Imagine a world where diseases could be cured more effectively, with fewer side effects and improved patient outcomes. Unfortunately, traditional pharmaceuticals often fall short...
